TCM Ltd

TCM Ltd, a micro-cap player in the commodity chemicals sector, has seen its investment rating upgraded from Strong Sell to Sell as of 16 March 2026. This change reflects a nuanced shift primarily driven by technical indicators, even as the company continues to grapple with weak financial fundamentals and challenging valuation metrics.

TCM Ltd, a player in the commodity chemicals sector, has seen its investment rating downgraded from Sell to Strong Sell as of 9 March 2026. This shift reflects deteriorating fundamentals, challenging valuation metrics, and a complex technical outlook, signalling heightened risk for investors amid a volatile market environment.

TCM Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 March 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

TCM Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 February 2026, providing investors with an up-to-date view of the company’s performance and outlook.

TCM Ltd, a player in the commodity chemicals sector, has reported a flat financial performance for the quarter ended December 2025, signalling a stabilisation after a period of decline. Despite a modest improvement in its financial trend score, the company continues to face challenges with net sales contracting and a cautious market outlook reflected in its current Mojo Grade of Sell.

TCM Limited, the micro-cap commodity chemicals firm formerly known as Travancore Chemical & Manufacturing Company Limited, reported a consolidated net loss of ₹1.14 crores for Q3 FY26, marking the company's ninth consecutive quarterly loss. Despite a marginal improvement in losses compared to the previous quarter, the company's operational struggles continue to weigh heavily on investor sentiment, with the stock trading at ₹53.00 and commanding a market capitalisation of just ₹39.63 crores.

TCM Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 05 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 February 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

TCM Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 05 January 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 29 January 2026, providing investors with the latest insights into the stock’s fundamentals, valuation, financial trends, and technical outlook.

TCM Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 5 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 January 2026, providing investors with the latest insights into the company’s performance and outlook.

TCM Ltd, a player in the Commodity Chemicals sector, has seen its investment rating upgraded from Strong Sell to Sell as of 31 Dec 2025, driven primarily by a marked improvement in technical indicators despite ongoing financial challenges. This nuanced shift reflects a complex interplay between quality, valuation, financial trends, and technicals, offering investors a comprehensive view of the stock’s current standing.

Recent revisions in the evaluation of TCM, a player in the commodity chemicals sector, highlight a complex interplay of financial challenges and evolving technical indicators. While the company’s financial results for the quarter ending September 2025 reveal operational losses and subdued sales, technical trends suggest a cautiously optimistic market sentiment. This article analyses the key parameters influencing the current assessment of TCM’s stock performance.

TCM Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 31 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 December 2025, providing investors with the latest insights into the company’s performance and outlook.

The stock of TCM, a microcap player in the Commodity Chemicals sector, has undergone a revision in its market evaluation reflecting a nuanced shift in its financial and technical outlook. Despite ongoing challenges in profitability and cash flow, recent assessment changes highlight a more optimistic technical perspective, prompting a reassessment of its market stance.

TCM, a key player in the Commodity Chemicals sector, reached a new 52-week high of Rs.81 today, reflecting a notable phase of momentum and market activity. This milestone underscores the stock’s recent performance strength amid a broadly positive market environment.

TCM Ltd has witnessed extraordinary buying momentum, hitting a fresh 52-week high of Rs. 74.33 with only buy orders in the queue, signalling a potential multi-day upper circuit scenario. The stock’s performance starkly contrasts with the broader market, reflecting robust investor enthusiasm in the commodity chemicals sector.

TCM, a key player in the Commodity Chemicals sector, reached a fresh 52-week high of Rs.74.33 today, underscoring a notable rally in its stock price amid broader market fluctuations.